Evogene Ltd.

Regulatory Filings • Feb 23, 2016

_________ false

C002����� ��"�2PublicEVOGENE LTD10571Corporation no: 512838723Stock Exchange/Market: -12369380Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: ofer.haviv@evogene.comReported via MAGNA: 23/02/2016              Time of broadcast: 17:04 16:52:52

Company site:		www.evogene.com

Reference: 2016-02-033271

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Evogene Discloses Positive Results in Yield Improvement Collaboration with Monsanto Utilizing Novel 'Trait-First' Methodology
PR__Positive_Results_in_Monsanto_Collaboration_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 31/01/2016
- - -
Name of the Signatory: : Masliah Sassi , Position of Signatory in the reporting corporation: Adv., Corporate Secretary , Name of Employer Company: .
Eizenberg Aharon Telephone: 08-9311971 , Facsimile: 08-9466724 , E-mail: sassi.masliah@evogene.com 1